Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Achilles Therapeutics has raised €59M across 1 funding round, most recently a round in Nov 2020. Based in Stevenage, UK; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-25 | Other | €59M |
| — |
| View deal → |
